Cargando…

Use of serotonin reuptake inhibitors and risk of subsequent bone loss in a nationwide population-based cohort study

This study examined whether the use of SRIs is associated with an increased risk of bone loss using a nested case–control design with a nationwide population–based cohort in Korea. Using the Korean National Health Screening Cohort, subjects newly diagnosed with osteoporosis or osteopenia (n = 55,799...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Sunyoung, Han, Minkyung, Park, Chun Il, Jung, Inkyung, Kim, Eun Hwa, Boo, Young Jun, Kang, Jee In, Kim, Se Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241982/ https://www.ncbi.nlm.nih.gov/pubmed/34188108 http://dx.doi.org/10.1038/s41598-021-92821-9

Ejemplares similares

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?
por: Chau, Kim, et al.
Publicado: (2012)

Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2017)

The Necessity of Bone Densitometry for Patients Taking Selective Serotonin Reuptake Inhibitors
por: An, Ki-Yong, et al.
Publicado: (2013)

Structural Requirements for Modulating 4-Benzylpiperidine Carboxamides from Serotonin/Norepinephrine Reuptake Inhibitors to Triple Reuptake Inhibitors
por: Paudel, Suresh, et al.
Publicado: (2021)

Serotonin reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local antiresorptive effect
por: Ortuño, María José, et al.
Publicado: (2016)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study
por: Jimenez-Solem, Espen, et al.
Publicado: (2012)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Selective serotonin reuptake inhibitor use in hip fracture patients: a Danish nationwide prevalence study
por: Bruun, Stine B, et al.
Publicado: (2019)

Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression
por: Kim, Hye-Geum, et al.
Publicado: (2019)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms
por: Wadhwa, Ravisha, et al.
Publicado: (2017)

Comparison of Treatment Adherence between Selective Serotonin Reuptake Inhibitors and Moclobemide in Patients with Social Anxiety Disorder
por: Lim, Se-Won, et al.
Publicado: (2012)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

COVID-19 mortality among selective serotonin reuptake inhibitor users—results from a nationwide cohort
por: Stauning, Marius Ahm, et al.
Publicado: (2023)

In utero and lactational exposure to the Selective Serotonin Reuptake Inhibitor fluoxetine compromises pup bones at weaning
por: Weaver, Samantha R., et al.
Publicado: (2019)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Briley, Mike, et al.
Publicado: (2010)

Prenatal exposure to serotonin reuptake inhibitors: a case report
por: Marsella, Maria, et al.
Publicado: (2010)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment
por: Alexeev, Vasiliy Grigorievich, et al.
Publicado: (2011)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
por: Diav-Citrin, Orna, et al.
Publicado: (2012)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011)

Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
por: Patel, Harish, et al.
Publicado: (2015)

Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
por: Jury, Nicholas J., et al.
Publicado: (2015)

Serotonin and Noradrenaline Reuptake Inhibitors Improve Micturition Control in Mice
por: Redaelli, Marco, et al.
Publicado: (2015)

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors
por: POP, ANCA, et al.
Publicado: (2015)

Selective Serotonin–norepinephrine Reuptake Inhibitors-induced Takotsubo Cardiomyopathy
por: Vasudev, Rahul, et al.
Publicado: (2016)

Ankle edema after administration of selective serotonin reuptake inhibitors
por: Kontoangelos, Konstantinos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8susmul3j08bt6l7j140e064pg